Mumbai, June 2, 2025 – Cipla Limited, one of India’s leading pharmaceutical companies, has announced the appointment of Prabhakaran Balakrishnan Nair as its new Global Chief Manufacturing Officer. Currently serving as Chief of Quality at Cipla’s Indore facility, Nair will step into his new role effective July 1, 2025. He has also been designated as a Senior Management Personnel of the company.

Bringing with him over three decades of rich experience in pharmaceutical manufacturing and quality assurance, Nair is widely respected for his strategic acumen and operational excellence. His professional journey spans 34 years, during which he has held significant leadership roles across renowned pharmaceutical organisations. Before his tenure at Cipla, he served as Chief Operating Officer at Encube Ethicals, where he was instrumental in scaling operations, launching new product lines, and leading greenfield expansions at sites in Goa and Indore.

Nair’s prior roles include leadership stints at ACG Worldwide, Dr. Reddy’s Laboratories, IPCA Laboratories, and Cadila Pharmaceuticals. Throughout his career, he has been credited with building high-performing teams, driving process excellence, and ensuring adherence to global regulatory standards.

Also Read :- Sun Pharma Bets on New Launches for FY26 Growth Amid Tax-Driven Profit Decline

At Cipla, Nair has played a pivotal role as Cluster Head within the Quality function. He is a member of the Cipla Leadership Group, contributing to strategic decision-making and quality governance. Under his leadership, the company has fortified its quality culture through structured assurance frameworks and rigorous regulatory compliance protocols. His forward-thinking approach has also led to the successful integration of advanced technologies, including AI-driven solutions, into the company’s quality operations.

Nair holds a Master of Pharmacy degree (1988) and a Master of Business Administration degree (1992), both from Mumbai University. His educational background, combined with extensive field experience, has equipped him to lead global manufacturing operations with a balance of technical depth and business insight.

Announcing the appointment, Cipla stated that Nair’s promotion is aligned with the company’s ongoing efforts to strengthen its global manufacturing footprint and operational resilience. With 47 manufacturing facilities worldwide producing over 1,500 products across more than 50 dosage forms, Cipla continues to invest in technological advancements and global quality standards to serve more than 80 markets.

Founded in 1935, Cipla is a global pharmaceutical leader known for its focus on sustainable growth and innovation. The company maintains a strong presence in India, South Africa, North America, and other key regulated and emerging markets, with core strengths in respiratory, anti-infective, cardiovascular, CNS, urology, and anti-retroviral segments.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!